Efficacy & Safety of QiShen YiQi Dripping Pills in the Treatment of

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05530356` - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed	`NCT05086549` - An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
Recruiting	`NCT05008276` - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed	`NCT02276196` - Effect of LIXIsenatide on the Renal System	Phase 4
Not yet recruiting	`NCT06120569` - Evaluate the Role of Soleus Muscle Exercise in Glycaemic Control in Diabetic Kidney Disease Patients	N/A
Completed	`NCT02545049` - Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease	Phase 3
Active, not recruiting	`NCT02237352` - Mechanisms of Diabetic Nephropathy in Ecuador
Active, not recruiting	`NCT06176599` - Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis	N/A
Recruiting	`NCT03716401` - Prognostic Imaging Biomarkers for Diabetic Kidney Disease
Terminated	`NCT03840343` - Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease	Phase 1
Completed	`NCT01377688` - Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes	N/A
Recruiting	`NCT05514548` - Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease	Phase 2
Recruiting	`NCT05507892` - Renal Mechanism of SGLT2 Inhibition	Phase 2
Not yet recruiting	`NCT06049550` - The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
Not yet recruiting	`NCT05514184` - Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease	N/A
Active, not recruiting	`NCT04589351` - Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe	Phase 3
Active, not recruiting	`NCT04531163` - Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy	Phase 2/Phase 3
Active, not recruiting	`NCT03620773` - Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes	Phase 1/Phase 2
Suspended	`NCT01878045` - Mechanisms of Diabetic Kidney Disease in American Indians
Completed	`NCT03627715` - Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan	Phase 2

NCT number	NCT06006689
Study type	Interventional
Source	Tasly Pharmaceutical Group Co., Ltd
Contact	Rui Liu
Phone	022-86343626
Email	liurui2@tasly.com
Status	Recruiting
Phase	Phase 2
Start date	September 4, 2023
Completion date	September 1, 2025

Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms